Click for full article regarding Ph.D. student Sarah McAnulty’s ‘Skype A Scientist’ program!
MCB News
Non-Coding Doesn’t Mean Non-Functioning
Click for full article regarding Dr. Leighton Core’s $2 million grant from the National Institute of General Medical Sciences.
Dr. Graf Elected as a Fellow in the American Academy of Microbiology
Click for full article regarding Dr. Joerg Graf’s election into the American Academy of Microbiology, an honorific leadership group within the American Society for Microbiology.
A Little Squid Sheds Light on Evolution with Bacteria
Click for full article on Dr. Spencer Nyholm’s study which sequences the genome of the Hawaiian bobtail squid.
Good Bacteria, Bad Bacteria: Uncovering How the Microbiome Supports Health
Click for full article on Dr. Nichole Broderick’s NHI grant supporting her study of the microbiome.
MCB Professional Science Master’s (PSM) Winter Courses
Exciting opportunities offered through the MCB Professional Science Master’s (PSM) program Winter Session 2019. Hands on training on state-of-the-art instruments through short, intense modular training courses. This winter we will be offering two modules. Open to graduate and undergraduate students with the required prerequisites.
Dr. Rachel O’Neill and graduate student, Kate Castellano, spent two weeks with a team of researchers from Woods Hole, OceanX, and NASA aboard the Alucia research vessel.
With the help of an underwater submersible, they were able sequence the DNA of coral ecosystems thousands of feet below the surface of the ocean; in the protected Northeast Canyons and Seamounts Marine National Monument, 130 miles off the coast of Massachusetts. Click here for the full National Geographic article.
Dr. Gogarten is featured in a newly published book
MCB Welcomed Dr. Raja Jothi, from NIH, at this year’s Khairallah Symposium
Tuesday, October 23rd, Dr. Raja Jothi, Senior Investigator and Chief, Systems Biology Section, NIEHS, NIH presented his talk entitled “Uncovering Unknown Unknowns of Gene Regulation,” made possible by The Dr. Edward A. Khairallah and Dr. Lamia H. Khairallah Fund for Scholarship.
Biohaven Pharmaceutical Company acquires an option to license an anti-metallothionein antibody from Michael Lynes for the treatment of inflammatory and autoimmune diseases.
This investment will develop the potential therapeutic applications that Dr. Lynes, his MCB lab group, and collaborators at the University of Gent and Joslin Diabetes Center have been working to elucidate.